This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.
Newly diagnosed stage I-III breast cancer.
Treatment-naïve; no neoadjuvant therapy planned.
Surgery scheduled at Moffitt in 1-2 months.
Post-menopausal.
Stage IV/metastatic disease.
Prior cancer.
Surgery scheduled sooner than 4-5 weeks.
NCI FVS ≥5 servings/day.